Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Clin Breast Cancer
    January 2018
  1. HASHEMI M, Sanaei S, Hashemi SM, Eskandari E, et al
    Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30804.
    >> Share

  2. ERSOY YE, Kadioglu H
    Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30830.
    >> Share

  3. GU J, Groot G, Boden C, Busch A, et al
    Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2018 Jan 3. pii: S1526-8209(17)30691.
    >> Share

    December 2017
  4. YADAV S, Ladkany R, Yadav D, Alhalabi O, et al
    Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Dec 30. pii: S1526-8209(17)30334.
    >> Share

  5. BHAVE MA, Speth KA, Kidwell KM, Lyden A, et al
    Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Clin Breast Cancer. 2017 Dec 27. pii: S1526-8209(17)30624.
    >> Share

  6. MORIKAWA A, Wang R, Patil S, Diab A, et al
    Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30394.
    >> Share

  7. GORNSTEIN EL, Sandefur S, Chung JH, Gay LM, et al
    BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30680.
    >> Share

  8. YERUVA SLH, Javadi MS, Stearns V
    Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30533.
    >> Share

  9. MEISEL J, Zhang C, Neely C, Mendoza P, et al
    Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.
    Clin Breast Cancer. 2017 Dec 14. pii: S1526-8209(17)30562.
    >> Share

  10. MOLDERINGS GJ, Knuchel-Clarke R, Hertfelder HJ, Kuhl C, et al
    Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30532.
    >> Share

  11. KUBA S, Maeda S, Matsumoto M, Yamanouchi K, et al
    Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30626.
    >> Share

  12. SHEPPARD VB, de Mendoza AH, He J, Jennings Y, et al
    Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30356.
    >> Share

  13. CHIBA A, Raman R, Thomas A, Lamy PJ, et al
    Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Clin Breast Cancer. 2017 Dec 11. pii: S1526-8209(17)30324.
    >> Share

  14. ELGHOROURY EA, ElDine HG, Kamel SA, Abdelrahman AH, et al
    Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 7. pii: S1526-8209(17)30458.
    >> Share

  15. SCIMECA M, Antonacci C, Toschi N, Giannini E, et al
    Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.
    Clin Breast Cancer. 2017 Dec 5. pii: S1526-8209(17)30209.
    >> Share

    November 2017
  16. BASTIAANNET E, Charman J, Johannesen TB, Schrodi S, et al
    A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Nov 29. pii: S1526-8209(17)30728.
    >> Share

  17. LANDMAN Y, Ilouze M, Wein S, Neiman V, et al
    Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30561.
    >> Share

  18. HAMELINCK VC, Bastiaannet E, Pieterse AH, van de Velde CJH, et al
    Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30409.
    >> Share

  19. RASOOL I, Afroze D, Wani KA, Yousuf A, et al
    Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30631.
    >> Share

  20. FURRER D, Jacob S, Michaud A, Provencher L, et al
    Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30318.
    >> Share

  21. FLEMING CA, McCarthy K, Ryan C, McCarthy A, et al
    Evaluation of Discordance in Primary Tumor and Lymph Node Response After Neoadjuvant Therapy in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30679.
    >> Share

  22. CHANG HT, Pan HJ, Lee CH
    Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30357.
    >> Share

  23. KIM JY, Jung EJ, Park HJ, Lee JH, et al
    Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30504.
    >> Share

  24. INOUE Y, Yamashita N, Kitao H, Tanaka K, et al
    Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30385.
    >> Share

  25. GRANDI G, Toss A, Cagnacci A, Marcheselli L, et al
    Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
    Clin Breast Cancer. 2017 Nov 14. pii: S1526-8209(17)30488.
    >> Share

  26. CHKHEIDZE R, Sanders MAG, Haley B, Leitch AM, et al
    Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
    Clin Breast Cancer. 2017 Nov 10. pii: S1526-8209(17)30456.
    >> Share

  27. KARAKAS Y, Dizdar O, Aksoy S, Hayran M, et al
    The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30449.
    >> Share

  28. HOU Y, Nitta H, Wei L, Banks PM, et al
    Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30604.
    >> Share

  29. RAGHAVENDRA A, Sinha AK, Valle J, Shen Y, et al
    Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30621.
    >> Share

  30. FIGUEIREDO FWDS, Adami F
    Income Inequality and Mortality Owing to Breast Cancer: Evidence From Brazil.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30526.
    >> Share

  31. WADASADAWALA T, Lewis S, Parmar V, Budrukkar A, et al
    Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30383.
    >> Share

  32. FISCHER A, Ziogas A, Anton-Culver H
    Negative Valence Life Events Promote Breast Cancer Development.
    Clin Breast Cancer. 2017 Nov 1. pii: S1526-8209(16)30501.
    >> Share

    October 2017
  33. MCREE AJ, Marcom PK, Moore DT, Zamboni WC, et al
    A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30313.
    >> Share

  34. MCVEIGH TP, Wiggins J, Ward S, Kemp Z, et al
    Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30489.
    >> Share

  35. PROCHOWSKI IAMURRI A, Ponziani M, Macchini M, Fogante M, et al
    Evaluation of Multifocality and Multicentricity With Breast Magnetic Resonance Imaging in Each Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30164.
    >> Share

  36. SALOUSTROS E, Nikolaou M, Kalbakis K, Polyzos A, et al
    Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group.
    Clin Breast Cancer. 2017 Oct 24. pii: S1526-8209(17)30153.
    >> Share

  37. HARDEFELDT PJ, Penninkilampi R, Edirimanne S, Eslick GD, et al
    Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies.
    Clin Breast Cancer. 2017 Oct 17. pii: S1526-8209(16)30429.
    >> Share

  38. KUROSKY SK, Mitra D, Zanotti G, Kaye JA, et al
    Treatment Patterns and Outcomes of Patients With Metastatic ER(+)/HER-2(-) Breast Cancer: A Multicountry Retrospective Medical Record Review.
    Clin Breast Cancer. 2017 Oct 14. pii: S1526-8209(17)30060.
    >> Share

  39. CHANG AE, Wu QV, Jenkins IC, Specht JM, et al
    Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 9. pii: S1526-8209(17)30280.
    >> Share

  40. JANDIAL R, Hoshide R, Waters JD, Somlo G, et al
    Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30417.
    >> Share

  41. HIEKEN TJ, Murphy BL, Boughey JC, Degnim AC, et al
    Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30370.
    >> Share

  42. RAISS H, Peron J, Tartas S, Trillet-Lenoir V, et al
    Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30072.
    >> Share

  43. HAYASHI N, Takahashi Y, Matsuda N, Tsunoda H, et al
    The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 3. pii: S1526-8209(17)30319.
    >> Share

    September 2017
  44. HOUSSAMI N
    Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
    Clin Breast Cancer. 2017 Sep 28. pii: S1526-8209(17)30558.
    >> Share

  45. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
    Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Clin Breast Cancer. 2017 Sep 27. pii: S1526-8209(17)30512.
    >> Share

  46. ITO T, Oura S, Nagamine S, Takahashi M, et al
    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241.
    >> Share

  47. LEAL AD, Van Houten H, Sangaralingham L, Freedman RA, et al
    Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.
    Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422.
    >> Share

  48. AKIMOTO E, Kadoya T, Kajitani K, Emi A, et al
    Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30037.
    >> Share

  49. WU J, Wang S, Liu F, Li S, et al
    Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30157.
    >> Share

  50. DIANATINASAB M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, et al
    Socioeconomic Factors, Health Behavior, and Late-Stage Diagnosis of Breast Cancer: Considering the Impact of Delay in Diagnosis.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30358.
    >> Share

  51. MANN JM, Wu X, Christos P, Nagar H, et al
    The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30461.
    >> Share

  52. SAFRA T, Kaufman B, Kadouri L, Efrat Ben-Baruch N, et al
    Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30180.
    >> Share

  53. SPINELLI VARELLA MA, Teixeira da Cruz J, Rauber A, Varella IS, et al
    Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(16)30505.
    >> Share

  54. OBERGUGGENBERGER A, Meraner V, Sztankay M, Hilbert A, et al
    Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors.
    Clin Breast Cancer. 2017 Sep 18. pii: S1526-8209(17)30454.
    >> Share

  55. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Pernas S, et al
    The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
    Clin Breast Cancer. 2017 Sep 4. pii: S1526-8209(17)30565.
    >> Share

  56. ANAMPA J, Chen A, Wright J, Patel M, et al
    Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(17)30468.
    >> Share

  57. ROGOZ B, Houze de l'Aulnoit A, Duhamel A, Houze de l'Aulnoit D, et al
    Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(16)30427.
    >> Share

    August 2017
  58. CHAMP CE, Ohri N, Klement RJ, Cantor M, et al
    Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.
    Clin Breast Cancer. 2017 Aug 24. pii: S1526-8209(17)30285.
    >> Share

  59. CHAO YL, Anders CK
    TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30369.
    >> Share

  60. WANG Y, Brodsky AS, Xiong J, Lopresti ML, et al
    Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30349.
    >> Share

  61. CID S, Eiro N, Fernandez B, Sanchez R, et al
    Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30189.
    >> Share

  62. CHOI WJ, Kim WK, Shin HJ, Cha JH, et al
    Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30058.
    >> Share

  63. AZIM HA, Abdel-Malek R, Kassem L
    Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30235.
    >> Share

  64. KOOL M, Bastiaannet E, Van de Velde CJH, Marang-van de Mheen PJ, et al
    Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30212.
    >> Share

  65. DONG H, Huang Y, Song F, Dai H, et al
    Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
    Clin Breast Cancer. 2017 Aug 15. pii: S1526-8209(17)30321.
    >> Share

  66. CHEN W, Huang Y, Lewis GD, Szeja SS, et al
    Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Clin Breast Cancer. 2017 Aug 10. pii: S1526-8209(17)30185.
    >> Share

  67. MOUNSEY LA, Deal AM, Keith KC, Benbow JM, et al
    Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
    Clin Breast Cancer. 2017 Aug 9. pii: S1526-8209(17)30036.
    >> Share

  68. ZHOU J, Guo FJ, Hao XP, Chen CJ, et al
    Use of Breast Magnetic Resonance Imaging and Ultrasonography for Identifying Nonpalpable Axillae Metastases in Newly Diagnosed Breast Cancer Patients.
    Clin Breast Cancer. 2017 Aug 9. pii: S1526-8209(17)30348.
    >> Share

    July 2017
  69. LI L, Pan Z
    Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials.
    Clin Breast Cancer. 2017 Jul 25. pii: S1526-8209(16)30358.
    >> Share

  70. NAMURA M, Tsunoda H, Yagata H, Hayashi N, et al
    Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Jul 21. pii: S1526-8209(17)30107.
    >> Share

  71. ALTUNDAG K
    Do We Consider Locoregional Treatment of Primary Site in Patients With De Novo Stage IV Breast Cancer?: Numerous Data Are Accumulating!
    Clin Breast Cancer. 2017 Jul 20. pii: S1526-8209(17)30443.
    >> Share

  72. THAKUR KK, Bordoloi D, Kunnumakkara AB
    Alarming Burden of Triple-negative Breast Cancer in India.
    Clin Breast Cancer. 2017 Jul 20. pii: S1526-8209(17)30160.
    >> Share

  73. GAITANIDIS A, Alevizakos M, Tsalikidis C, Tsaroucha A, et al
    Refusal of Cancer-Directed Surgery by Breast Cancer Patients: Risk Factors and Survival Outcomes.
    Clin Breast Cancer. 2017 Jul 18. pii: S1526-8209(17)30381.
    >> Share

  74. OTSUBO R, Hirakawa H, Oikawa M, Baba M, et al
    Validation of a Novel Diagnostic Kit Using the Semidry Dot-Blot Method to Detect Metastatic Lymph Nodes in Breast Cancer: Distinguishing Macrometastases From Nonmacrometastases.
    Clin Breast Cancer. 2017 Jul 15. pii: S1526-8209(17)30274.
    >> Share

  75. PARK AY, Seo BK, Han H, Cho KR, et al
    Clinical Value of Real-Time Ultrasonography-MRI Fusion Imaging for Second-Look Examination in Preoperative Breast Cancer Patients: Additional Lesion Detection and Treatment Planning.
    Clin Breast Cancer. 2017 Jul 14. pii: S1526-8209(17)30167.
    >> Share

  76. CINAUSERO M, Gerratana L, De Carlo E, Iacono D, et al
    Determinants of Last-line Treatment in Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Jul 14. pii: S1526-8209(17)30270.
    >> Share

  77. ALBESHAN SM, Mackey MG, Hossain SZ, Alfuraih AA, et al
    Breast Cancer Epidemiology in Gulf Cooperation Council Countries: A Regional and International Comparison.
    Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30108.
    >> Share

  78. BATISTATOU A, Kotoula V, Bobos M, Kouvatseas G, et al
    Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.
    Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30138.
    >> Share

  79. DESNYDER SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, et al
    Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(17)30366.
    >> Share

  80. GERSTL B, Sullivan E, Ives A, Saunders C, et al
    Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(16)30537.
    >> Share

  81. OSBORNE C, Challagalla JD, Eisenbeis CF, Holmes FA, et al
    Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(16)30521.
    >> Share

  82. MONTAGNA E, Pirola S, Maisonneuve P, De Roberto G, et al
    Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(17)30085.
    >> Share

  83. FRATAMICO RS, Strickland KS, Uppal G, Abu-Khalaf M, et al
    A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia.
    Clin Breast Cancer. 2017 Jul 4. pii: S1526-8209(17)30092.
    >> Share

    June 2017
  84. YOKOYAMA S, Tamaru S, Tamaki S, Nakanishi D, et al
    Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy.
    Clin Breast Cancer. 2017 Jun 29. pii: S1526-8209(17)30142.
    >> Share

  85. COLLARINO A, de Koster EJ, Valdes Olmos RA, de Geus-Oei LF, et al
    Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
    Clin Breast Cancer. 2017 Jun 29. pii: S1526-8209(17)30059.
    >> Share

  86. STEGER GG, Dominguez A, Dobrovolskaya N, Giotta F, et al
    Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.
    Clin Breast Cancer. 2017 Jun 27. pii: S1526-8209(16)30562.
    >> Share

  87. IBRAHIM M, Muanza T, Smirnow N, Sateren W, et al
    A Pilot Randomized Controlled Trial on the Effects of a Progressive Exercise Program on the Range of Motion and Upper Extremity Grip Strength in Young Adults With Breast Cancer.
    Clin Breast Cancer. 2017 Jun 24. pii: S1526-8209(17)30032.
    >> Share

  88. CHEN T, Zhang N, Moran MS, Su P, et al
    Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2017 Jun 23. pii: S1526-8209(16)30550.
    >> Share

  89. PARK S, Lee JE, Yu J, Paik HJ, et al
    Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane.
    Clin Breast Cancer. 2017 Jun 21. pii: S1526-8209(16)30518.
    >> Share

  90. CHOI SH, Kim JW, Choi J, Sohn J, et al
    Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
    Clin Breast Cancer. 2017 Jun 17. pii: S1526-8209(17)30306.
    >> Share

  91. FU J, Wu L, Fu W, Tan Y, et al
    How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype.
    Clin Breast Cancer. 2017 Jun 8. pii: S1526-8209(17)30033.
    >> Share

  92. SHAKER OG, Helmy HS
    Circulating Bone-related Markers and YKL-40 Versus HER2 and TOPO2a in Bone Metastatic and Nonmetastatic Breast Cancer: Diagnostic Implications.
    Clin Breast Cancer. 2017 Jun 7. pii: S1526-8209(17)30150.
    >> Share

  93. ROBERT NJ, Denduluri N
    Patient Case Lessons: Endocrine Management of Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Jun 7. pii: S1526-8209(16)30502.
    >> Share

    May 2017
  94. YU E, Huang D, Leonard K, Dipetrillo T, et al
    Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Clin Breast Cancer. 2017 May 25. pii: S1526-8209(17)30115.
    >> Share

  95. CHO YT, Su H, Chiang YY, Shiea J, et al
    Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
    Clin Breast Cancer. 2017 May 25. pii: S1526-8209(16)30538.
    >> Share

  96. LOURENCO AP, Benson KL, Henderson MC, Silver M, et al
    A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
    Clin Breast Cancer. 2017 May 23. pii: S1526-8209(16)30412.
    >> Share

  97. BASELGA J, Zamagni C, Gomez P, Bermejo B, et al
    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2017 May 22. pii: S1526-8209(17)30005.
    >> Share

  98. ADRASKELA K, Veisaki E, Koutsilieris M, Philippou A, et al
    Physical Exercise Positively Influences Breast Cancer Evolution.
    Clin Breast Cancer. 2017 May 19. pii: S1526-8209(16)30357.
    >> Share

  99. BUONO G, Giuliano M, De Angelis C, Lauria R, et al
    Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.
    Clin Breast Cancer. 2017 May 19. pii: S1526-8209(17)30168.
    >> Share

  100. BIGLIA N, Bounous VE, D'Alonzo M, Ottino L, et al
    Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists.
    Clin Breast Cancer. 2017 May 19. pii: S1526-8209(17)30095.
    >> Share

  101. RAHBAR A, Touma J, Costa H, Davoudi B, et al
    Low Expression of Estrogen Receptor-alpha and Progesterone Receptor in Human Breast Cancer Tissues Is Associated With High-Grade Human Cytomegalovirus Protein Expression.
    Clin Breast Cancer. 2017 May 11. pii: S1526-8209(16)30411.
    >> Share

  102. NOGI H, Uchida K, Mimoto R, Kamio M, et al
    Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 May 8. pii: S1526-8209(17)30221.
    >> Share

  103. HUSSEIN MM, Gaafar RM, Abdel-Warith AM, Ahmed WA, et al
    Efficacy and Toxicity of Metronomic Chemotherapy in Metastatic Breast Cancer: Egyptian Experience.
    Clin Breast Cancer. 2017 May 8. pii: S1526-8209(17)30007.
    >> Share

  104. DIANATINASAB M, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M, et al
    Hair Coloring, Stress, and Smoking Increase the Risk of Breast Cancer: A Case-Control Study.
    Clin Breast Cancer. 2017 May 5. pii: S1526-8209(17)30135.
    >> Share

    April 2017
  105. WERNER TL, Ray A, Lamb JG, VanBrocklin M, et al
    A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
    Clin Breast Cancer. 2017 Apr 29. pii: S1526-8209(16)30425.
    >> Share

  106. LI X, Yang J, Krishnamurti U, Huo L, et al
    Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
    Clin Breast Cancer. 2017 Apr 28. pii: S1526-8209(16)30531.
    >> Share

  107. EL ZEIN D, Hughes M, Kumar S, Peng X, et al
    Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    Clin Breast Cancer. 2017 Apr 26. pii: S1526-8209(16)30556.
    >> Share

  108. MOHAMMADI A, Mansoori B, Baradaran PC, Khaze V, et al
    Urtica dioica Extract Inhibits Proliferation and Induces Apoptosis and Related Gene Expression of Breast Cancer Cells In Vitro and In Vivo.
    Clin Breast Cancer. 2017 Apr 21. pii: S1526-8209(16)30347.
    >> Share

  109. AMORNSUPAK K, Jamjuntra P, Warnnissorn M, O-Charoenrat P, et al
    High ASMA+ Fibroblasts and Low Cytoplasmic HMGB1+ Breast Cancer Cells Predict Poor Prognosis.
    Clin Breast Cancer. 2017 Apr 21. pii: S1526-8209(16)30580.
    >> Share

  110. VAN NIJNATTEN TJA, Simons JM, Smidt ML, van der Pol CC, et al
    A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch
    Clin Breast Cancer. 2017 Apr 19. pii: S1526-8209(17)30130.
    >> Share

  111. HERMEL DJ, Wood ME, Chun J, Rounds T, et al
    Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer.
    Clin Breast Cancer. 2017 Apr 14. pii: S1526-8209(16)30264.
    >> Share

  112. BELLIO G, Marion R, Giudici F, Kus S, et al
    Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis.
    Clin Breast Cancer. 2017 Apr 11. pii: S1526-8209(17)30174.
    >> Share

  113. LAMBERTINI M, Ferreira AR, Di Meglio A, Poggio F, et al
    Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Clin Breast Cancer. 2017 Apr 11. pii: S1526-8209(17)30046.
    >> Share

  114. MADUNIC J, Horvat L, Majstorovic I, Jodlowska I, et al
    Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells.
    Clin Breast Cancer. 2017 Apr 6. pii: S1526-8209(17)30106.
    >> Share

    March 2017
  115. ZHANG X, Bleiweiss I, Jaffer S, Nayak A, et al
    The Impact of 2013 Updated ASCO/CAP HER2 Guidelines on the Diagnosis and Management of Invasive Breast Cancer: A Single-Center Study of 1739 Cases.
    Clin Breast Cancer. 2017 Mar 29. pii: S1526-8209(16)30360.
    >> Share

  116. MENDEZ-HERNANDEZ A, Gallegos-Arreola MP, Moreno-Macias H, Espinosa Fematt J, et al
    LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 Polymorphisms Are Associated With Obesity and Chemotherapy Response in Mexican Women With Breast Cancer.
    Clin Breast Cancer. 2017 Mar 22. pii: S1526-8209(16)30246.
    >> Share

  117. WADASADAWALA T, Vadgaonkar R, Bajpai J
    Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities.
    Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(16)30416.
    >> Share

  118. GINTER PS, McIntire PJ, Cui X, Irshaid L, et al
    Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(17)30012.
    >> Share

  119. VIDAL GA, Chen M, Sheth S, Svahn T, et al
    Phase I Trial of Everolimus and Capecitabine in Metastatic HER2- Breast Cancer.
    Clin Breast Cancer. 2017 Mar 16. pii: S1526-8209(16)30410.
    >> Share

  120. BERNARDO A, Palumbo R, Pedersini R, Rota Caremoli E, et al
    Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.
    Clin Breast Cancer. 2017 Mar 9. pii: S1526-8209(16)30359.
    >> Share

  121. CHAND AR, Ziauddin MF, Tang SC
    Can Locoregionally Recurrent Breast Cancer Be Cured?
    Clin Breast Cancer. 2017 Mar 2. pii: S1526-8209(17)30113.
    >> Share

    February 2017
  122. ALTUNDAG K
    Flap Fixation Using Tissue Glue or Sutures After Mastectomy Might Also Reduce Risk of Developing Lymphedema in Breast Cancer.
    Clin Breast Cancer. 2017 Feb 20. pii: S1526-8209(17)30061.
    >> Share

  123. ALTUNDAG K
    Molecular Subtypes and Lower Inner Quadrant Tumors in Breast Cancer: Debate Is Still Ongoing.
    Clin Breast Cancer. 2017 Feb 17. pii: S1526-8209(17)30019.
    >> Share

  124. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
    Can MTHFR C677T and A1298C Polymorphisms Alter the Risk and Severity of Sporadic Breast Cancer in Brazilian Women?
    Clin Breast Cancer. 2017 Feb 16. pii: S1526-8209(16)30341.
    >> Share

  125. WANG CH, Chang CJ, Yeh KY, Chang PH, et al
    The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2017 Feb 16. pii: S1526-8209(17)30086.
    >> Share

    January 2017
  126. LEFEUVRE D, Le Bihan-Benjamin C, Pauporte I, Medioni J, et al
    French Medico-Administrative Data to Identify the Care Pathways of Women With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 27. pii: S1526-8209(16)30321.
    >> Share

  127. VAN BASTELAAR J, Theunissen LL, Snoeijs MG, Beets GL, et al
    Flap Fixation Using Tissue Glue or Sutures Appears to Reduce Seroma Aspiration After Mastectomy for Breast Cancer.
    Clin Breast Cancer. 2017 Jan 24. pii: S1526-8209(16)30565.
    >> Share

  128. DE BOER MC, Worner EA, Verlaan D, van Leeuwen PA, et al
    The Mechanisms and Effects of Physical Activity on Breast Cancer.
    Clin Breast Cancer. 2017 Jan 24. pii: S1526-8209(16)30422.
    >> Share

  129. CHAPMAN JW, Liu S, Leung S, Nielsen TO, et al
    Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 20. pii: S1526-8209(16)30362.
    >> Share

  130. LI G, Xu Z, Zhuang A, Chang S, et al
    Magnetic Resonance Spectroscopy-Detected Change in Marrow Adiposity Is Strongly Correlated to Postmenopausal Breast Cancer Risk.
    Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30011.
    >> Share

  131. GHONCHEH M, Ziaee F, Karami M, Poorolajal J, et al
    Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
    Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30010.
    >> Share

  132. GU YL, Pan SM, Ren J, Yang ZX, et al
    Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
    Clin Breast Cancer. 2017 Jan 11. pii: S1526-8209(16)30256.
    >> Share

  133. SCHRAMM A, Schochter F, Friedl TW, de Gregorio N, et al
    Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30257.
    >> Share

  134. HWANG KT, Kim J, Kim EK, Jung SH, et al
    Poor Prognosis of Lower Inner Quadrant in Lymph Node-negative Breast Cancer Patients Who Received No Chemotherapy: A Study Based on Nationwide Korean Breast Cancer Registry Database.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30269.
    >> Share

  135. CONVERSANO A, Mazouni C, Thomin A, Gaudin A, et al
    Use of Low-Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30449.
    >> Share

  136. GOLSE N, Adam R
    Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30298.
    >> Share

  137. NYE L, Rademaker A, Gradishar WJ
    Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30313.
    >> Share

  138. MURPHY BL, Boughey JC, Hieken TJ
    Nipple-sparing Mastectomy for the Management of Recurrent Breast Cancer.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30355.
    >> Share

  139. ALTUNDAG K
    New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30426.
    >> Share

  140. ALTUNDAG K
    Genomic Profiling of Brain Metastasis and Matched Primary Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30409.
    >> Share

  141. SHEPPARD VB, Cavalli LR, Dash C, Kanaan YM, et al
    Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 6. pii: S1526-8209(16)30571.
    >> Share

  142. DENU RA, Burkard ME
    Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome.
    Clin Breast Cancer. 2017 Jan 5. pii: S1526-8209(16)30577.
    >> Share

    December 2016
  143. JONES EF, Ray KM, Li W, Seo Y, et al
    Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Clin Breast Cancer. 2016 Dec 29. pii: S1526-8209(16)30576.
    >> Share

  144. YAN M, Wang J, Xuan Q, Dong T, et al
    The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30569.
    >> Share

  145. AL-BAHLANI SM, Al-Bulushi KH, Al-Alawi ZM, Al-Abri NY, et al
    Cisplatin Induces Apoptosis Through the Endoplasmic Reticulum-mediated, Calpain 1 Pathway in Triple-negative Breast Cancer Cells.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30566.
    >> Share

  146. PEREIRA CB, Leal MF, Abdelhay ES, Demachki S, et al
    MYC Amplification as a Predictive Factor of Complete Pathologic Response to Docetaxel-based Neoadjuvant Chemotherapy for Breast Cancer.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30570.
    >> Share

  147. BENEDICT C, Thom B, Teplinsky E, Carleton J, et al
    Family-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine Therapy.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30567.
    >> Share

    November 2016
  148. XIAO F, Song X, Chen Q, Dai Y, et al
    Effectiveness of Psychological Interventions on Depression in Patients After Breast Cancer Surgery: A Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30494.
    >> Share

  149. GIATROMANOLAKI A, Sivridis E, Kalamida D, Koukourakis MI, et al
    Transcription Factor EB Expression in Early Breast Cancer Relates to Lysosomal/Autophagosomal Markers and Prognosis.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30497.
    >> Share

  150. TSENG CH
    Sitagliptin May Reduce Breast Cancer Risk in Women With Type 2 Diabetes.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30493.
    >> Share

  151. SATO K, Akimoto K
    Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30496.
    >> Share

  152. VILLARREAL-GARZA C, Mohar A, Bargallo-Rocha JE, Lasa-Gonsebatt F, et al
    Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30498.
    >> Share

  153. MUZAFFAR M, Kachare S, Vohra N
    Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer.
    Clin Breast Cancer. 2016 Nov 22. pii: S1526-8209(16)30492.
    >> Share

    October 2016
  154. RYU JM, Park S, Paik HJ, Nam SJ, et al
    Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Clin Breast Cancer. 2016 Oct 27. pii: S1526-8209(16)30373.
    >> Share

  155. KIM SH, Shin HJ, Shin KC, Chae EY, et al
    Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30374.
    >> Share

  156. OJINNAKA CO, Luo W, Ory MG, McMaughan D, et al
    Disparities in Surgical Treatment of Early-Stage Breast Cancer Among Female Residents of Texas: The Role of Racial Residential Segregation.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30370.
    >> Share

  157. LEINERT E, Singer S, Janni W, Harbeck N, et al
    The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30372.
    >> Share

  158. MARRAZZO A, Damiano G, Taormina P, Buscemi S, et al
    Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
    Clin Breast Cancer. 2016 Oct 18. pii: S1526-8209(16)30365.
    >> Share

    September 2016
  159. DUCHNOWSKA R, Jarzab M, Zebracka-Gala J, Matkowski R, et al
    Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2016 Sep 8. pii: S1526-8209(16)30238.
    >> Share

    August 2016
  160. GAO JJ, Tan M, Pohlmann PR, Swain SM, et al
    HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.
    Clin Breast Cancer. 2016 Aug 27. pii: S1526-8209(16)30235.
    >> Share

  161. GLUCK S
    Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30234.
    >> Share

  162. PIVO S, Montes J, Schwartz S, Chun J, et al
    Breast Cancer Risk Assessment and Screening in Transgender Patients.
    Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30233.
    >> Share

  163. JASRA S, Opyrchal M, Norton L, Mehta R, et al
    A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.
    Clin Breast Cancer. 2016 Aug 18. pii: S1526-8209(16)30211.
    >> Share

  164. CADOO KA, Morris PG, Cowell EP, Patil S, et al
    Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
    Clin Breast Cancer. 2016 Aug 1. pii: S1526-8209(16)30206.
    >> Share

    July 2016
  165. YARDLEY DA, Reeves J, Dees EC, Osborne C, et al
    Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
    Clin Breast Cancer. 2016 Jul 29. pii: S1526-8209(16)30198.
    >> Share

  166. CHOI WJ, Cha JH, Kim HH, Shin HJ, et al
    The Accuracy of Breast MR Imaging for Measuring the Size of a Breast Cancer: Analysis of the Histopathologic Factors.
    Clin Breast Cancer. 2016 Jul 29. pii: S1526-8209(16)30200.
    >> Share

  167. DUDANI S, Mazzarello S, Hilton J, Hutton B, et al
    Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30207.
    >> Share

  168. XUAN Q, Gao K, Song Y, Zhao S, et al
    Adherence to Needed Adjuvant Therapy Could Decrease Recurrence Rates for Rural Patients With Early Breast Cancer.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30199.
    >> Share

  169. ZHU W, Harvey S, Macura KJ, Euhus DM, et al
    Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30202.
    >> Share

  170. TECALCO-CRUZ AC, Ramirez-Jarquin JO
    Mechanisms that Increase Stability of Estrogen Receptor Alpha in Breast Cancer.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30208.
    >> Share

  171. WILKINSON JB, Shah C, Amin M, Nadeau L, et al
    Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30203.
    >> Share

  172. SMITH JW 2ND, Buyse ME, Rastogi P, Geyer CE Jr, et al
    Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Tri
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30201.
    >> Share

  173. MORIKAWA A, Jordan L, Rozner R, Patil S, et al
    Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30177.
    >> Share

  174. EDENFIELD J, Schammel C, Collins J, Schammel D, et al
    Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30197.
    >> Share

  175. FOGLIETTA J, Inno A, de Iuliis F, Sini V, et al
    Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30196.
    >> Share

  176. HARRIS SR
    Differentiating the Causes of Spontaneous Rib Fracture After Breast Cancer.
    Clin Breast Cancer. 2016 Jul 15. pii: S1526-8209(16)30176.
    >> Share

  177. PARK S, Lee JE, Paik HJ, Ryu JM, et al
    Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
    Clin Breast Cancer. 2016 Jul 9. pii: S1526-8209(16)30175.
    >> Share

  178. TANAKA K, Tokunaga E, Inoue Y, Yamashita N, et al
    Impact of Expression of Vimentin and Axl in Breast Cancer.
    Clin Breast Cancer. 2016 Jul 5. pii: S1526-8209(16)30170.
    >> Share

  179. S CHAPMAN J, Roddy E, Panighetti A, Hwang S, et al
    Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.
    Clin Breast Cancer. 2016 Jul 5. pii: S1526-8209(16)30171.
    >> Share

    June 2016
  180. LEE J, Jung JH, Kim WW, Hwang SO, et al
    Five-Year Oncologic Outcomes of Volume Displacement Procedures After Partial Mastectomy for Breast Cancer.
    Clin Breast Cancer. 2016 Jun 29. pii: S1526-8209(16)30173.
    >> Share

  181. NAVARRO-RODRIGUEZ E, Diaz-Jimenez N, Ruiz-Rabelo J, Gomez-Luque I, et al
    Factors Associated With Disease Recurrence in Breast Cancer Patients With Negative Sentinel Lymph Node Biopsy.
    Clin Breast Cancer. 2016 Jun 27. pii: S1526-8209(16)30168.
    >> Share

  182. VARILLA V, Taxel P, Tannenbaum S
    Metastatic Inflammatory Breast Cancer Associated With Multicentric Reticulohistiocytosis Successfully Treated With Zoledronic Acid.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30166.
    >> Share

  183. DE IULIIS F, Salerno G, Corvino R, D'Aniello D, et al
    Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30165.
    >> Share

  184. ONO M, Tsuda H, Yoshida M, Shimizu C, et al
    Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30167.
    >> Share

  185. CINIERI S, Chan A, Altundag K, Vandebroek A, et al
    Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30169.
    >> Share

  186. DAUGHERTY EC, Daugherty MR, Bogart JA, Shapiro A, et al
    Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30172.
    >> Share

  187. RAMAN R, Mott SL, Schroeder MC, Phadke S, et al
    Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30163.
    >> Share

  188. BUFI E, Belli P, Di Matteo M, Giuliani M, et al
    Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30162.
    >> Share

  189. TAKAHASHI H, Kagara N, Tanei T, Naoi Y, et al
    Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Clin Breast Cancer. 2016 Jun 16. pii: S1526-8209(16)30148.
    >> Share

  190. TZANNINIS IG, Kotteas EA, Ntanasis-Stathopoulos I, Kontogianni P, et al
    Management and Outcomes in Metaplastic Breast Cancer.
    Clin Breast Cancer. 2016 Jun 15. pii: S1526-8209(16)30144.
    >> Share

  191. GIULIANI M, Patrolecco F, Rella R, Di Giovanni SE, et al
    Can Breast Cancer Biopsy Influence Sentinel Lymph Node Status?
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30147.
    >> Share

  192. JEHN CF, Hemmati P, Lehenbauer-Dehm S, Kummel S, et al
    Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30143.
    >> Share

  193. ABRAMOVITZ M, Williams C, Loibl S, Leyland-Jones B, et al
    Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast Cancer.
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30146.
    >> Share

  194. AYTAC HO, Nursal TZ, Colakoglu T, Bolat FA, et al
    Seroma Cytology in Breast Cancer: An Underappreciated Issue.
    Clin Breast Cancer. 2016 Jun 8. pii: S1526-8209(16)30142.
    >> Share

  195. CEBERIO N, Cuadra M, Mendizabal JL, Gorostiaga J, et al
    Should We Perform the Intraoperative Sentinel Lymph Node Biopsy in Breast Cancer?
    Clin Breast Cancer. 2016 Jun 8. pii: S1526-8209(16)30141.
    >> Share

  196. TAKEI J, Tsunoda H, Yagata H, Suzuki K, et al
    Sustained Interruption of Anterior Interfaces Between Adipose Tissues and Mammary Glands in Ultrasonography After Complete Pathological Remission After Neoadjuvant Chemotherapy for Primary Breast Cancer.
    Clin Breast Cancer. 2016;16:196-201.
    >> Share

    May 2016
  197. NEUHAUS V, Abdullayev N, Hellmich M, Kramer S, et al
    Association of Quality and Quantity of Bone Metastases and Computed Tomography Volumetric Bone Mineral Density With Prevalence of Vertebral Fractures in Breast Cancer Patients.
    Clin Breast Cancer. 2016 May 31. pii: S1526-8209(16)30106.
    >> Share

  198. SHIINO S, Kinoshita T, Yoshida M, Jimbo K, et al
    Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30110.
    >> Share

  199. AZGHADI S, Daly M, Mayadev J
    Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30105.
    >> Share

  200. NAKAUCHI C, Kagara N, Shimazu K, Shimomura A, et al
    Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30100.
    >> Share

  201. YARDLEY DA, Ward PJ, Daniel BR, Eakle JF, et al
    Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30102.
    >> Share

  202. GANZ PA, Hahn EE, Petersen L, Melisko ME, et al
    Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena).
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30099.
    >> Share

  203. TANG Y, Wang Y, Kiani MF, Wang B, et al
    Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30108.
    >> Share

  204. CHANG JS, Chen J, Weinberg VK, Fowble B, et al
    Evaluation of Heart Dose for Left-Sided Breast Cancer Patients Over an 11-Year Period Spanning the Transition From 2-Dimensional to 3-Dimensional Planning.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30109.
    >> Share

  205. ALGAN O, Zhao YD, Herman T
    Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30107.
    >> Share

  206. PETRELLI F, Di Cosimo S, Lonati V, Barni S, et al
    Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30098.
    >> Share

    April 2016
  207. HAMELINCK VC, Bastiaannet E, Pieterse AH, de Glas NA, et al
    A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer.
    Clin Breast Cancer. 2016 Apr 21. pii: S1526-8209(16)30083.
    >> Share

    March 2016
  208. OHNO S
    Tolerability of Therapies Recommended for the Treatment of Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Mar 12. pii: S1526-8209(16)30049.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016